Outline
| Name |
Saito Bio Incubator |
| Address |
7-7-15 Asagi, Saito, Ibaraki-shi, Osaka |
Facility type
|
Incubator for university (specialized in biotechnology.) |
Main university
|
Osaka University |
| Maintainer |
Organization for Small & Medium Enterprises and Regional Innovation, JAPAN
*Organization receives the investment from the general account of Japan, and acuires the land and builds Saito Bio Incubator on it. |
| Internet URL |
http://www.bs-capital.co.jp/saito/ |
| Founded |
July, 2004 |
| Telephone |
072-640-1060 |
| E-mail |
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
| Status |
20 companies are located in Saito Bio Incubator at the time of of May, 2008 (full occupancy) |
Business expense
|
1.82 billion yen (including about 600 million yen of site purchase cost
(the national supplementary budget of 2002 fiscal year : METI) |
| Business scale |
Land: About 6,100 square meters in Saito Life Science
Facility: About 4,900 square meters as a total floor space (about 3,700 square meters for a rent) |
| Management scheme |
Built with funds by government and operated as private company
(Administrator: Bio-Sight Capital, Inc.)
|
Aims to establishment
In order to accelerate the ratio of creation of venture business derived of university, the facility for venture business that the person opens a business utilizing results of university's research is provided rental offices and rental research rooms with low fee and the growth is supported and accelerated was constructed.
Tenant list of Saito Bio Incubator (May 2008)
|
|
Name
|
Business Domain
|
|
1
|
AnGes MG, Inc.
|
Development and research of gene therapy medicine and relating gene medicine
|
|
2
|
Kringle Pharma, Inc.
|
- The research and development of the NK4 gene therapy medicine and the related.
- Business for research and development of NK4 protein medicine
- Business to make HGF protein medicine
- Business for epoch-making drug development from Japan
|
|
3
|
GeneDesign Inc.
|
Funded research around the genetic research(biotechnology outsourcing)
|
|
4
|
Genolac BL Corp.
|
- Medicine development that uses protein appearance technology to lactic acid bacterium surface
- New product creation through Porigammagltamin acid
|
|
5
|
ACA, Inc.
|
- Development of organic high polymer chemistry
- Sales of new product of wooden structure material and polymer
|
|
6
|
Med-Solution, Inc. |
- Making, Processing, and Analysis of multi-dimensional living body image by living body image processing system for medical treatment
- Services of clinical support and operation support that use the above system
|
|
7
|
Nihon Kohken, Inc.
|
Import and sales of collagen, and Manufacturing and sales of detergent with enzyme.
|
|
8
|
Soiken Inc.
|
Research and development of biomarker and living body evaluation system, and the trust of evaluation test on medicine and food.
|
|
9
|
Fujikin, Inc.
|
Research and development, manufacturing, and sales of precise fluid control equipment. Development of medical equipment.
|
|
10
|
St. Louis international, Inc.
|
Research and development of plant biotechnology and application in fields of beauty and medical treatment.
|
|
11
|
Mouhatsu Clinic Reve 21, Inc.
|
Medical treatment service for growing hair. And the development and sales of related product.
|
|
12
|
Jenomidhia, Inc.
|
Analysis on gene and antibody that used HVJ-E Envelope Vector and the development of DDS (drug delivery system) technology.
|
|
13
|
MedGEL Corporation
|
Development and sales of regenerative medicine material and DDS technology
|
|
14
|
Sunny Health Holdings, Inc.
|
Development and sales such as diet foods, health food, and cosmetics
|
|
15
|
Anti Cancer Japan, Inc.
|
- Trusted research into anti-cancer drug evaluation and license of evaluation technology.
- Research and development of technology to make image of cancer and biological reaction
- Development and sales of the optical image analysis device for small animals
- Research, development, and sales of experimental transgenic mouse for anti-cancer drug research
|
|
16
|
Interprotein Corporation
|
- Drug development(development of original medicine)
- Incubation(promotion of making to business of literary property)
|
|
17
|
JTEC Corporation
|
- Design, production, and sales of the automatic control unit
- Design, production, and sales of electronic measurement equipment
- Development and manufacturing of microcomputer application and electricity equipments
- Development and sales of computer software
|
|
18
|
Hokudo Co.,Ltd
|
We are supporting the life science research by using the function of the animal and the cell. And we are contributing to the life science research by the trust research like reagent manufacturing by a joint research with university, peptide production, rearrangement protein production, antibody production, trust research and pharmacological test and inspection including Assei system construction.
|
|
19
|
THERAVALUES Corp.
|
- Research and development and manufacturing and sales of functional food and supplement
- Research and development of protein analysis
|
|
20
|
Non-profit organization
Evidence Soushutsusha Kurabu
|
To do the promotion activity of EBM (medical treatment based on evidence and grounds) in Japan, and to contribute to the improvement of the public interest in the field of the health, the medical treatment, and the welfare, we do the following activity.
- Execution and support business of clinical research
- Execution and support business of basic medicine research
- Execution and support business of immunology
- Execution support business of resident medical examination
- Collection, preservation management, and analytical business of medical information
- Development and distribution business of open source electronic clinical record and related software
- Researcher dispatch business to holding of lecture meeting, society, and academic society and domestic and foreign academic societies
|
Establishment of the authorization of bio incubation facilities
| Background |
"The summary about the authorization of biotechnology incubation facilities in Saito Life Science Park in Osaka" (Enforced on September 1, 2005) |
| Aim |
To establish the authorization system of biotechnology incubation facilities as a incentive of the preparation of the biotechnology incubator by private companies in Saito Life Science Park, the establishment environment of the biotechnology venture will be maintained, and promote it's concentration, and the construction of Saito Bio Cluster will be promoted actively. |
| Effect |
The company that moved into the authorized facility wii be able to obtain the assistance that equals Saito Bio Incubator. |
Authorization
condition
|
(1) The facility has to be in Saito Life Science Park |
| |
(2) The facility has to be used as a incubation one in least 5 years. |
| |
(3) The facility has to have a support function to venture companies that are moved into. |
| |
(4) The facility has to offer the environment that companies in the facility can research.
|
| |
(5) The facility has to have a impartial and fair selection standard.
|
| |
(6) The facility has to have a suitable scale for incubation facilities. |
Outline of
the authorized
facilities |
(The facility of Yahima Pure Chemicals Co.,Ltd. was authorized at January 12, 2006) |
| |
| 1 Applicant: |
Yahima Pure Chemicals Co.,Ltd.
The President and Representative Director
Yoshihiro Hirooka |
| 2 Name: |
Saito Bio Hills Center |
| 3 Management: |
Bio Sight Capital, Inc. |
4 Structure,
number of floors,
and architectural area: |
Iron frame and partially ferroconcrete make |
| |
The 3rd floor (883.8 square meters) that is a part of the 5 floors (3575 square meters) that have 4 floors on the ground and 1 floor in underground. |
| 5 Research infrastructure: |
Physical containment level P1 (Correspond to maximum P2. ) |
6 Area of room for rent,
number of rooms,
and cost of rent |
76.4 square meters (9 rooms) 200,550 yen/room/month (including sales tax and separately common area charge) |
| |
69.2 square meters (1 room) 181,650 yen/room/month (including sales tax and separately common area charge) |
| 7 Term of the auth: |
From April 1, 2006 to March 31, 2011
(It is possible to continue. ) |
| 8 Status: |
6 companies have moved in May, 2008. (full) |
|
|